In line with our prior observation that GSDME was readily detectable in non-small cell lung cancer (NSCLC) (Lu et al., 2018), a panel of 30 cell lines exhibited a range of GSDME and GSDMD protein levels in immunoblotting analysis (Figure 1A). This evidence concerns the gene GSDMD and non-small cell lung carcinoma.